Clearside Biomedical, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2016 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Clearside Biomedical, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2016 to Q2 2024.
  • Clearside Biomedical, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 9, 2024 was 74.7M shares, a 20.5% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 74.7M +12.7M +20.5% Aug 9, 2024 10-Q 2024-08-12
Q1 2024 74.7M +13.4M +21.8% Mar 5, 2024 10-K 2024-03-12
Q3 2023 62.4M +2.22M +3.69% Nov 8, 2023 10-Q 2023-11-13
Q2 2023 62M +1.84M +3.06% Aug 10, 2023 10-Q 2023-08-14
Q1 2023 61.4M +1.22M +2.02% Mar 8, 2023 10-K 2023-03-14
Q3 2022 60.2M +524K +0.88% Nov 7, 2022 10-Q 2022-11-09
Q2 2022 60.2M +711K +1.2% Aug 10, 2022 10-Q 2022-08-12
Q1 2022 60.1M +2.73M +4.75% Mar 7, 2022 10-K 2022-03-11
Q3 2021 59.7M +11.3M +23.4% Nov 5, 2021 10-Q 2021-11-10
Q2 2021 59.5M +13.1M +28.3% Aug 6, 2021 10-Q 2021-08-10
Q1 2021 57.4M +12.6M +28% Mar 10, 2021 10-K 2021-03-15
Q3 2020 48.4M +7.2M +17.5% Nov 6, 2020 10-Q 2020-11-10
Q2 2020 46.3M +8.58M +22.7% Aug 7, 2020 10-Q 2020-08-10
Q1 2020 44.9M +8.83M +24.5% Mar 11, 2020 10-K 2020-03-13
Q3 2019 41.1M +9.13M +28.5% Nov 4, 2019 10-Q 2019-11-08
Q2 2019 37.8M +5.74M +17.9% Aug 5, 2019 10-Q 2019-08-08
Q1 2019 36M +4.13M +12.9% Mar 11, 2019 10-K 2019-03-15
Q3 2018 32M +6.68M +26.4% Nov 2, 2018 10-Q 2018-11-08
Q2 2018 32M +6.69M +26.4% Aug 6, 2018 10-Q 2018-08-08
Q1 2018 31.9M +6.63M +26.2% Mar 12, 2018 10-K 2018-03-16
Q3 2017 25.3M +4.77M +23.2% Nov 9, 2017 10-Q 2017-11-09
Q2 2017 25.3M +4.79M +23.3% Aug 4, 2017 10-Q 2017-08-11
Q1 2017 25.3M Mar 10, 2017 10-K 2017-03-16
Q3 2016 20.6M Nov 10, 2016 10-Q 2016-11-14
Q2 2016 20.5M Aug 5, 2016 10-Q 2016-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.